MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA
As listed in the register: MNEXSPIKE DISPERSION INYECTABLE EN JERINGA PRECARGADA
10 microgramos · dispersion inyectable en jeringa precargada
- Prescription only
- Antibiotics, antivirals and antifungals taken into the body
- Active substance
- Vacuna anti COVID-19 (Moderna) ARNm para XBB.1.5 (provisional)
- Made by
- Moderna Biotech Spain S.L.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
CanadaNo exact match for this strength and form
Netherlands5 matching products
- Comirnaty JN.1 10 microgram/dosis 10 microgram/dosis · dispersie voor injectie2 makers
- Comirnaty KP.2 10 microgram/dosis dispersie voor injectie 10 microgram/dosis · dispersie voor injectie
- Comirnaty LP.8.1 10 microgram/dosis dispersie voor injectie 10 microgram/dosis · dispersie voor injectie
- Comirnaty XFG 10 microgram/dosis dispersie voor injectie 10 microgram/dosis · dispersie voor injectie
SwitzerlandNo exact match for this strength and form
Details
| Made by | Moderna Biotech Spain S.L. |
|---|---|
| Active substance | Vacuna anti COVID-19 (Moderna) ARNm para XBB.1.5 (provisional) |
| Used in | Antibiotics, antivirals and antifungals taken into the body |
| Strength | 10 microgramos |
| Form | dispersion inyectable en jeringa precargada |
| Classification | J07BN01 · Antibiotics, antivirals and antifungals taken into the body |
| Route | vía intramuscular |
| Marketed | No — authorised but not currently marketed, according to the register |
| Additional monitoring ▼ | Yes — under additional monitoring (black triangle). Report suspected side effects. |
| Nº Registro | 1252010004 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.